 WARREN, N.J., Oct. 19, 2022 GLOBE NEWSWIRE -- Aquestive Therapeutics, Inc. NASDAQ: AQST, a pharmaceutical company advancing current standards of care to solve patients problems through simplifying complex delivery methods, today announced that it will report results for third quarter ended September 30, 2022, and provide an update on recent developments in its business after market close on Tuesday, November 1, 2022. 